Myriad Genetics Suspends Testing Operations Following Unauthorized IT Network Access
Myriad Genetics (MYGN) has temporarily suspended its testing operations and order management systems following an unauthorized breach of its IT network on November 2. The company is currently conducting a thorough investigation to determine the root cause of the incident and the extent of the data or system compromise. The disruption affects the company's ability to process orders and manage diagnostic testing services. While the full scope of the impact remains under investigation, the suspension of core operational systems represents a significant interruption to its service delivery capabilities.
Tickers: $MYGN
Topics: cyberattack data security operational disruption
Read the full article at Seeking Alpha
Part of the story MYRIAD GENETICS INC - 8-K Filing (4 articles)